Objective: Estimation of dietary intake of polyphenols is difficult, due to limited availability of food composition data and bias inherent to dietary assessment methods. The aim of the present study was to evaluate whether we could detect polyphenols and their metabolites in a spot urine sample in a free-living human population and whether it was related to those observed in 24-h urine samples, for potential use as a biomarkers of polyphenol intake. Subjects: Four 24-h urine samples and two spot urine samples were collected from 154 participants of the SU.VI.MAX cohort (a randomized primary-prevention trial evaluating the effect of daily antioxidant supplementation on chronic diseases) in two separate studies over, respectively, a 7-and 2-day periods. Thirteen polyphenols and metabolites (chlorogenic acid (CGA), caffeic acid (CA), m-coumaric acid (mCOU), gallic acid (GA), 4-O-methylgallic acid (MeGA), quercetin (Q), isorhamnetin (MeQ), kaempferol (K), hesperetin (HESP), naringenin (NAR), phloretin (PHLOR), enterolactone (ENL) and enterodiol (END) were measured using HPLC-ESI-MS-MS. Results: Correlations between the urinary excretion levels were observed. The most significant were explained by metabolic filiations (CGA/CA, CA/mCOU, GA/MeGA, Q/MeQ, NAR/PHLOR, ENL/END) or co-occurrence in a same food source (NAR/ HESP). Concentrations in spot samples correlated with those in 24-h urine sample (Po0.02, except for CA and for MeQ). Intraindividual variations were smaller than inter-individual variations for all polyphenols (Po0.01) except for MeGA and for PHLOR. Conclusion: These results show that these polyphenols and metabolites are useful biomarkers for polyphenol intake.
Introduction
Polyphenols are compounds with high-antioxidant properties and are probably the most abundant antioxidants in our diet (Scalbert and Williamson, 2000) . Both experimental and epidemiological evidence support a role of polyphenols in the prevention chronic diseases and more particularly cardiovascular diseases and cancers . Polyphenol intake has been related to disease in epidemiological studies, and especially inverse associations with cardiovascular risk have been observed (Hertog et al., 1993; Knekt et al., 1996; Hirvonen et al., 2001) .
Many different types of polyphenols can be found in plant foods, one plant often containing more than one type of polyphenols and progress in epidemiological research on the relation between polyphenol consumption and disease is largely hampered by the lack of complete food composition tables. Although some food composition data are available for polyphenols, especially on the USDA website, content values for some polyphenol types or foods only consumed in specific countries are still missing. Furthermore, there is no gold standard for collection of dietary intake data, which is always subject to a certain under-or overestimation (Block, 1982; Bingham, 1991) . The use of valid biomarkers for intake may be of help where the estimation of dietary intake is particularly difficult (Bingham, 2002) ; the advantage of biomarkers in dietary assessment being that their random errors are truly random and not dependent on those involved in dietary questionnaires (Kaaks, 1997) . Measurements of compounds in spot urine samples are ideal potential biomarkers as they are relatively easy to obtain in large epidemiological studies.
The aim of the present study was, therefore, to evaluate whether we could detect polyphenols and their metabolites in a spot urine sample in a free-living human population and whether it was related to those observed in 24-h urine samples, for potential use as a biomarker of polyphenol intake. An HPLC-ESI-MS-MS was developed to analyse 13 different phenolic compounds in urine samples (Ito et al., 2005) . It has been first validated using urine samples from controlled clinical trials and is applied here to urine samples collected from free-living subjects.
Subjects and methods

Subjects
Subjects were participants of the SU.VI.MAX study, a randomized double-blind placebo-controlled primaryprevention trial evaluating the effect of daily antioxidant supplementation (vitamin C, vitamin E, b-carotene, selenium and zinc) at nutritional doses on the incidence of cancer and ischemic heart disease. The cohort comprised women in the age of 35-60 years (mean: 46.4, s.d.: 6.7) and men in the age of 45-60 years (mean: 51.1, s.d.: 4.7) at baseline in 1994, and none of them used vitamin supplements other than those under study. In total, 13 077 subjects were included and were followed up for 8 years. Details on recruitment and study design are described elsewhere (Hercberg et al., 2004) . SU.VI.MAX subjects living in the Parisian area were invited in 2002 to participate in a satellite protocol on the validation of a salt questionnaire, for which 154 subjects participated (study 1). The next year out of these 154 subjects, 53 were asked to and completed correctly another protocol to evaluate the measurement of polyphenols in urine as a biomarker for polyphenol intake (study 2) and were included in the present analyses. Of them, 31 were women and 22 were men and the mean age was 58 years at the time of the protocol.
The SU.VI.MAX study has been approved by the ethical committee for studies on human subjects (CCPPRB No. 706) of Paris-Cochin Hospital, and the 'Comité National Informatique et Liberté' (CNIL No. 334641) , which advocates that all medical information is confidential and anonymous.
Data collection
The first study included a 7-day protocol during which subjects collected 24-h urine on days 2, 4 and 6. The subjects indicated the total urine volume for each collection and kept a tube of each mixture, which were later collected by a dietician. No validation of the 24-h urine collection was performed for this study.
For the second study, subjects were first visited by a trained dietician to explain the 2-day protocol. The morning of the first day the subjects started a 2-day dietary record. The morning of the second day, the first-spot urine sample (spot 1) was collected. The collection of the 24-h urine started right after the collection of the spot sample and lasted until the following day at the same hour. During the 24-h period, three p-aminobenzoic acid tablets were taken, one after the collection of the spot sample, one at 1600 and one at 2300 to check the completeness of the 24-h urine collection. Only those subjects for whom a recovery of 85% or more was measured (53 subjects) were included for the subsequent analyses. The second-spot sample (spot 2) was taken in the morning of the third day and was thus part of the 24-h urine collection. On the first day, the subjects did not eat or drink after 2300 and they brought the three tubes with the collected urine (two spot and one tube taken from the mixed 24-h urine) to the study centre after the completion of the 24-h urine collection. The tubes were stored at À201 until measurement of the polyphenols.
Polyphenol measurements
An HPLC-ESI-MS-MS offering a high selectivity of detection for a wide range of phenolic compounds and short run times was developed (Ito et al., 2005) . In brief, urine samples (250 ml) were supplemented with an internal standard (taxifolin), incubated with b-glucuronidase and sulfatase (from Helix pomatia, Sigma G0876; Sigma, St Louis, MO, USA), and extracted with ethyl acetate. The organic extracts were redissolved in 25% aqueous methanol and injected into the HPLC-ESI-MS-MS system using a short Zorbax Eclipse XDB-C18 (2.1 i.d. Â 30 mm, 3.5 mm, Agilent, Massy, France) and an API-2000 (Applied Biosystems, Canada) mass spectrometer. A 4-min gradient of water-formic acid (100:0.1) and acetonitrile-water-formic acid (95:5:0.1) was applied. The whole cycle including elution and reequilibration of the column did not exceed 6 min per sample. Mass detection was carried out with negative ionization in multiple reaction monitoring mode.
Calibration curves were prepared by spiking blank urine with aliquots of standard mixture solutions with duplicated injections at each concentration level. Determination of catechin and epicatechin was not included in the present study due to an insufficient sensitivity of the mass spectrometer for these compounds and a too low concentration in the urine samples.
Statistical analysis
Mean, median, 10th and 90th percentile for all polyphenols and metabolites were calculated for measurements of the second study. Spearman's rank correlation coefficients were calculated to evaluate the relation between the spot and 24-h urine sample and between different polyphenols. Kappa coefficients were calculated to evaluate the agreement across tertiles of polyphenol concentrations for the different samples. This analysis provides information on the level of misclassification when data are treated in tertiles, as is often caried out in statistical analyses of large epidemiological studies. Intra-and inter-individual variations were calculated with analyses of variance, using data of the 24-h urine collection of both the first and the second study (four collections in total per subject).
Results
Thirteen phenolic compounds were analysed by HPLC-ESI-MS-MS in urine samples collected from 53 free-living subjects. Three types of compounds were found in urine: compounds found in their native form after deconjugation with enzymes (chlorogenic acid, caffeic acid, gallic acid, quercetin, kaempferol, hesperetin, naringenin and phloretin), methylated metabolites formed in the host tissues (4-Omethylgallic acid and isorhamnetin) and microbial metabolites formed in the colon (m-coumaric acid, enterolactone and enterodiol).
In the 24-h urine samples, enterolactone was found in the highest quantity, followed by caffeic acid and naringenin, whereas lower amounts of isorhamnetin, quercetin and kaempferol were found (Table 1) .
Analysis of the levels of urinary excretion of the different phenolic compounds revealed the following correlations: chlorogenic acid correlated well with caffeic acid, quercetin and isorhamnetin, whereas caffeic acid also correlated with m-coumaric acid, isorhamnetin, kaempferol and naringenin (Table 2) . Gallic acid correlated with 4-O-methylgallic acid, isorhamnetin and naringenin. Phloretin correlated with isorhamnetin, kaempferol and naringenin. Hesperetin correlated with naringenin and 4-O-methylgallic acid. Enterodiol correlated with enterolactone, quercetin and isorhamnetin.
The concentration of polyphenols in the first-and the second-spot samples all correlated well with the concentration in the 24-h urine sample, except for caffeic acid in both spot samples and for isorhamnetin in the first-spot samples (Table 3 ). The kappa coefficient was statistically significant (Po0.05) for all correlations between the concentrations in the 24-h urine sample and in the second-spot sample. This was also the case for most of the polyphenols measured in the first-spot samples, except for kaempferol and naringenin. As expected, correlations were stronger for the second spot urine samples, which were part of the 24-h urine samples. The intra-individual variation was smaller than the inter-individual variation for all polyphenols except for 4-O-methylgallic acid and for phloretin (Table 4) . 
Discussion
The use of tandem mass spectrometry to estimate polyphenols in urine implies that a range of polyphenols is selected a priori. Thirteen phenolic compounds were selected for their widespread occurrence in the human diet, and for being representative of the main types of polyphenol classes (Ito et al., 2005) . It is therefore possible that other compounds other than those measured here are also suitable as biomarkers for polyphenol intake. Isoflavones were not included due to the low consumption of soy-containing products, the main dietary source of isoflavones, in France.
Catechins were not included due to too limited sensitivity with the method developed for analysis. Using the same method, they have been estimated in a clinical trial in samples collected after intake of polyphenol-rich beverages (Ito et al., 2005) . However, attempts to detect catechins with the same method in the urine of free-living subjects were unsuccessful. The relative excretion of polyphenols in urine depends on their intake and on their bioavailability (Manach et al., 2004 and concentration values in 24-h urine differ according to polyphenols. They can be compared to those published previously (Table 5 ). Coffee is one of the main dietary source of chlorogenic acid. Mean urinary excretion of chlorogenic acid observed in the cohort is close to that observed after consumption of about two cups of instant coffee (Ito et al., 2005) . Gallic acid is present in food either in a free form or esterified to flavanols. Comparison of gallic acid and 4-O-methylgallic acid recovery in urine after ingestion of either wine or tea suggested a low urinary recovery when gallic acid is ingested in an esterified form (Ito et al., 2005) . Urinary excretion of gallic acid and 4-Omethylgallic acid in the present cohort is about six times higher than that observed after consumption of one cup of tea (Ito et al., 2005) . It is also higher than that observed after 4 weeks of regular tea consumption (Hodgson et al., 2000) . This suggests that the subjects ingested another dietary source of gallic acid which could be wine, known to contain higher concentration of the more easily absorbed free gallic acid.
Flavonols (quercetin, isorhamnetin and kaempferol), flavanones (naringenin and hesperetin) and dihydrochalcones (phloretin) originate mainly from the consumption of fruits and vegetables. Except for hesperetin, excretion levels of the other flavonoids are somewhat higher than those observed previously in two Danish studies, in which the subjects ingested either their habitual diet or a diet rich in fruit and vegetables (Table 5 ). Our average concentration of enterolactone also seems high as compared to those reported in several other studies (reviewed in Horn-Ross et al. (1997) ) and is more comparable to the one in women following a macrobiotic diet (Adlercreutz et al., 1986) . It is known that a French population, in general, eats more fruits and vegetables than a general population in Anglo-Saxon countries, were most of the previous studies have been carried out, and this may be one reason for the higher values (Beer-Borst et al., 2000) .
Some correlations were found between the excretion levels of the different phenolic compounds. Strongest correlations are explained by metabolic filiations such as for chlorogenic acid and caffeic acid (hydrolysis) (Gonthier et al., 2003) , gallic acid and 4-O-methylgallic acid, quercetin and isorhamnetin (methylation), enterolactone and enterodiol (hydrolysis and reduction) (Borriello et al., 1985) . We also reported in a previous study the excretion of phloretin after consumption of citrus juice and suggested that phloretin is a metabolite of naringenin formed by reductive opening of the heterocycle (Ito et al., 2005) . This explains the high correlation observed here between these two compounds. mCoumaric acid is also weakly correlated to caffeic acid and is formed by microbial dehydroxylation of the latter in the colon (Gonthier et al., 2003) .
Correlations between other polyphenols can be explained by co-occurrence in a given food. This is the case for the correlation between hesperetin and naringenin (both found in orange and orange juice; Ito et al. (2005) . Citrus juice also contains quercetin (Belajova and Suhaj, 2004) and this may explain the correlations observed between naringenin and isorhamnetin. Quercetin or isorhamnetin are correlated to enterodiol, the former being found in various vegetables and the latter being produced from various vegetables (Kirkman et al., 1995) . Kaempferol and quercetin originate in plants from a common precursor (dihydrokaempferol) and their occurrence in plants may be linked and explain the observed correlation between kaempferol on one side and quercetin and its O-methylated metabolite isorhamnetin on the other side. Similar co-occurrences in foods may explain other weak correlations observed between some flavonoids (quercetin, kaempferol and naringenin) and caffeic acid, chlorogenic acid or gallic acid.
The results of the present study show a good correlation between polyphenols measured in a spot sample and in a 24-h urine sample collected during a same day, indicating that a spot sample may be used to assay potential biomarkers of polyphenol intake. The only polyphenol for which we did not find a relation between the concentration measured in the spot sample and in that measured in the 24 urine sample is caffeic acid. We have no explanation for this lack of association, but it means that caffeic acid measured in a spot sample is probably not suitable for use as a biomarker. As far as we know no other study has published correlations between polyphenols concentrations measured in a 24-h urine sample and a spot sample. Krogholm et al. (2004) evaluated flavonoids in both a 24-h urine and a spot urine sample, but did not correlate the two. Weaker correlations were observed between polyphenols measured in a spot sample collected the day before the collection of the 24-h urine sample. This is expected due to the irregular consumption of various polyphenol food sources over successive days.
Intra-individual variation can be due to variation in the measurement and/or due to variation in the dietary intake of the individuals. Intra-individual variations are higher for some polyphenols. Variations observed for compounds like chlorogenic acid and gallic acid are relatively low. This may be due to the regular consumption by French adults of the studied population of coffee and wine, respectively, main dietary sources of these two polyphenols. The higher intraindividual variations observed for other polyphenols could be due to the more irregular consumption of their main dietary source (citrus juice and fruits for hesperetin and naringenin, or apple for phloretin) or to their microbial origin (enterolactone and enterodiol).
The higher ratio of inter-over intra-individual variation for all measured compounds, except for 4-O-methylgallic acid and phloretin suggests that they are potentially useful biomarker of polyphenol intake in an epidemiological setting. Indeed when in nutritional epidemiological studies intra-individual variation of the nutritional variable is lower than the inter-individual variation, it becomes possible to detect a relation between the variable and the disease, or markers of disease of interest.
In conclusion, chlorogenic acid, m-coumaric acid, gallic acid, quercetin, isorhamnetin, kaempferol, hesperetin, naringenin, enterolactone and enterodiol measured in spot urine samples are potentially useful biomarkers for polyphenol intake. Few authors have examined so far correlations between polyphenol intake and polyphenol excretion in urine in free-living populations (Maskarinec et al., 1998; Lampe et al., 1999; Hodgson et al., 2004) . We recently showed that urinary polyphenols correlate with intake of various polyphenol-rich food and beverages (Mennen et al., 2006) . Further research evaluating the relation of the concentration of these polyphenols in urine with dietary polyphenol intake is necessary to validate their use as biomarkers in large epidemiological studies.
